Ken Griffin Sight Sciences, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 2,200 shares of SGHT stock, worth $13,618. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,200Holding current value
$13,618% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding SGHT
# of Institutions
69Shares Held
21.1MCall Options Held
33.2KPut Options Held
27.7K-
Kck Ltd. Tortola, D84.65MShares$28.8 Million22.26% of portfolio
-
Bank Of America Corp Charlotte, NC3.16MShares$19.6 Million0.0% of portfolio
-
Ubs Group Ag2.87MShares$17.8 Million0.0% of portfolio
-
Jackson Square Partners, LLC San Francisco, CA1.61MShares$9.97 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.56MShares$9.63 Million0.0% of portfolio
About Sight Sciences, Inc.
- Ticker SGHT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,826,200
- Market Cap $296M
- Description
- Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...